Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease

Motor symptoms are a core feature of Parkinson’s disease (PD) and cause a significant burden on patients’ quality of life. Oral levodopa is still the most effective treatment, however, the motor benefits are countered by inherent pharmacologic limitations of the drug. Additionally, with disease prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Luca, Daniel Garbin, Reyes, Nikolai Gil D., Fox, Susan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287529/
https://www.ncbi.nlm.nih.gov/pubmed/35841520
http://dx.doi.org/10.1007/s40265-022-01747-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287529/
https://www.ncbi.nlm.nih.gov/pubmed/35841520
http://dx.doi.org/10.1007/s40265-022-01747-7

Ejemplares similares